Unresectable Gallbladder Carcinoma Recruiting Phase 1 Trials for Gemcitabine (DB00441)

IndicationStatusPhase
DBCOND0046852 (Unresectable Gallbladder Carcinoma)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02495896Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid TumorsTreatment